The causes of type 1 diabetes,
Role: PI,
Cambridge Institute for Medical Research,
(11/2015 - 11/2016)
Status: Completed
Federal
Hyperbaric oxygen enhances function of transplanted human islets in type 1 diabetes. Assessment by MRI.,
Role: Principal Investigator,
National Medical Technology Testbed, Inc.,
(02/2009 - 03/2011)
Status: Closed
In vivo dynamic imaging of angiogenesis in transplanted islets,
Role: Principal Investigator,
National Institutes of Health/DHHS,
(09/2006 - 07/2010)
Status: Closed
For Profit Organization
The genetics and neuroendocrinology of short stature international study (GeNeSIS),
Role: PI,
Eli Lilly & Co.,
(10/2015 - 10/2016)
Status: Completed
An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who are Prescribed Norditropin (Human Growth Hormone) Version 5.0, 01/12/10,
Role: PI,
Novo Nordisk Pharmaceuticals Inc.,
(09/2015 - 09/2016)
Status: Completed
Increlex™ (mecasermin [rDNA origin] injection) growth forum database - IGFD registry: A patient registry for monitoring long-term safety and efficacy of Increlex,
Role: Investigator,
Tercica, Inc.,
(02/2012 - 02/2013)
Status: Completed
Pfizer International Growth Study (KIGS): An International, Non-Interventional, Safety, Multi-Center Open Label Study: Genotropin,
Role: PI,
Pharmacia,
(09/2011 - 09/2012)
Status: Completed
DEFEND2: Durable-response therapy evaluation for early or new onset Type I Diabetes,
Role: PI,
Tolerx, Inc,
(01/2011 - 01/2012)
Status: Completed
Genentech National Cooperative Growth Study (NCGS) Postmarketing surveillance program for Nutropin Depot, Nutropin AQ, and Protropin,
Role: Investigator,
Genentech, Inc.,
(10/2009 - 10/2010)
Status: Completed
Basal/bolus therapy with insulin aspart (NovoLog) versus regular human insulin (Novolin R) or insulin lispro (Humalog) in combination with NPH: an open-label, randomized, parallel group, multicenter study in children and adolescents with Type I diabetes,
Role: PI,
Novo Nordisk Pharmaceuticals Inc.,
(04/2004 - 04/2005)
Status: Completed
A randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of anastrozole versus placebo for the treatment of gynecomastia in pubaertal boys,
Role: Investigator,
AstraZeneca LP (USA),
(04/2001 - 04/2002)
Status: Completed
A study of juveniles with diabetes mellitus comparing the Glucowatch automatic glucose biographer with a hemocue photometer over a 15-hour period,
Role: PI,
Cygnus, Inc.,
(11/2000 - 11/2001)
Status: Completed
Internal
Database for patients at the Pediatric Diabetes Center,
Role: PI,
LLU Dept. of Pediatrics,
(07/2021 - 07/2022)
Status: Completed
Effect of a Gluten-Free Diet on Ameliorating New-Onset Type 1 Diabetes Mellitus in Children and Adolescents,
Role: Principal Investigator,
LLU Dept. of Pediatrics,
(01/2016 - 12/2023)
Status: Closed
MEND Program effectiveness study: Type I diabetes and chronic kidney disease,
Role: Investigator,
LLU Dept. of Counseling & Family Sciences,
(12/2015 - 12/2016)
Status: Completed
Continous glucose measurement using the GlucoWatch G2 biographer in infants of diabetic mothers,
Role: Investigator,
LLU Dept. of Pediatrics,
(10/2005 - 10/2006)
Status: Completed
Pretransplant growth modulation of pancreatic islets,
John Mace Pediatric Research Fund,
(07/2003 - 06/2015)
Status: Closed
Genetics of obesity study (G.O.O.S.),
Role: PI,
LLU Dept. of Pediatrics,
Status: Completed
Non-Profit Organization
Detection of human beta cell death in type I diabetes by methylation-specific PCR,
Role: PI,
Juvenile Diabetes Research Foundation,
(04/2015 - 04/2016)
Status: Completed
Detection of Human Beta Cell Death in T1DM by Methylation-Specific PCR,
Role: Principal Investigator,
City of Hope,
(06/2012 - 06/2013)
Status: Closed
In vivo imaging of revascularization in islet transplantation,
Role: Principal Investigator,
American Diabetes Association, Inc.,
(01/2007 - 12/2007)
Status: Closed